Login
← Go Back
Shilpa Medicare
SHILPAMED · Pharma > Pharmaceuticals & Drugs · Chairman: Omprakash Inani · MD: Vishnukant Bhutada · Listing date: Dec. 4, 2009 · Employees: 2350 · Raichur · http://www.vbshilpa.com
Stock Price vs Company Growth
1d
1.2%
1w
1.9%
1m
16.9%
3m
20.7%
6m
32.0%
1y
25.4%
5y
6.7%
10y
3.5%
all
15.7%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 328 1.2%
322
429
Company Overview
Sales
1,342 Cr
Growth: 9.9%
Profit after Tax
137 Cr
Growth: 23.5%
Small Cap
6,409 Cr
P/E: 55.7x
Industry P/E: 32.3x
Fundamentals
Sales (Cr) ₹ 1,342
Growth 9.9%
EBITDA 26.6%
P/S 4.8x
Dividend 0.0%
P/E 55.7x
Book Value ₹ 126
PEG Ratio 5.6x
ROE 6.0%
P/B 2.6x
Shareholding Pattern
Institutions
Ta Fii Investors Fund
3.71 %
Tano Mauritius India Fvci Ii
2.43 %
Pivotal Enterprises Private Limited
2.35 %
Pivotal Business Managers Llp
1.75 %
Duro One Investments Limited
1.42 %
Promoters
Vishnukant Chaturbhuj Bhutada
7.81 %
Dharmavati Bhutada
7.61 %
Ravi Kumar Innani
4.91 %
Suraj Kumar Innani
4.88 %
Ramakant Innani
4.29 %
Others
Increase    Decrease    No change
Company Profile Detailed
Shilpa Medicare, established in 1987, has carved a niche for itself in the exceedingly competitive and quality-conscious sphere of pharmaceuticals manufacturing. It produces and exports consistently high-quality Active Pharmaceutical Ingredients Fine Chemicals, intermediates, herbal products and speciality chemical products using sophisticated technology, meticulously following international specifications.
Belongs to (10 Indices) view more
Investors (148)
india.op...
vishnuka...
ubs.ag
Followers (8)
nitin2
keerthi
deepak